140 related articles for article (PubMed ID: 37330168)
1. Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPĪ± expression.
Wang Q; Zhang L; Su Z; Li W; Jia Y; Zhang J
Pulm Pharmacol Ther; 2023 Oct; 82():102227. PubMed ID: 37330168
[TBL] [Abstract][Full Text] [Related]
2. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.
Li J; Han Y; Zhang H; Qian Z; Jia W; Gao Y; Zheng H; Li B
Biochem Biophys Res Commun; 2019 May; 512(3):479-485. PubMed ID: 30905413
[TBL] [Abstract][Full Text] [Related]
3. Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.
Xiao P; Liu YK; Han W; Hu Y; Zhang BY; Liu WL
Mol Cancer Res; 2021 Apr; 19(4):726-738. PubMed ID: 33563765
[TBL] [Abstract][Full Text] [Related]
4. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
5. Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m
Zhang QC; Qian YM; Ren YH; Chen MM; Cao LM; Zheng SJ; Li BB; Wang M; Wu X; Xu K
Acta Pharmacol Sin; 2024 Mar; 45(3):619-632. PubMed ID: 37848553
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.
Mo WL; Deng LJ; Cheng Y; Yu WJ; Yang YH; Gu WD
Aging (Albany NY); 2021 Apr; 13(8):11629-11645. PubMed ID: 33879631
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Wu J; Wang X; Li X
Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
[TBL] [Abstract][Full Text] [Related]
8. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA prostate cancer-associated transcript 6 inhibited gefitinib sensitivity of non-small cell lung cancer by serving as a competing endogenous RNA of miR-326 to up-regulate interferon-alpha receptor 2.
Zheng Y; Guo Z; Li Y
Bioengineered; 2022 Feb; 13(2):3785-3796. PubMed ID: 35081872
[TBL] [Abstract][Full Text] [Related]
10. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
[TBL] [Abstract][Full Text] [Related]
11. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
[TBL] [Abstract][Full Text] [Related]
12. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of m6A-related genes in TP53-mutant non-small-cell lung cancer.
Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Zhou F; Li Z; Ming L
J Clin Lab Anal; 2022 Jan; 36(1):e24118. PubMed ID: 34812534
[TBL] [Abstract][Full Text] [Related]
14. m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.
Gao M; Qi Z; Feng W; Huang H; Xu Z; Dong Z; Xu M; Han J; Kloeber JA; Huang J; Lou Z; Liu S
J Biol Chem; 2022 Feb; 298(2):101563. PubMed ID: 34998823
[TBL] [Abstract][Full Text] [Related]
15. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
[TBL] [Abstract][Full Text] [Related]
16. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L
BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441
[TBL] [Abstract][Full Text] [Related]
17. Interaction of FLNA and ANXA2 promotes gefitinib resistance by activating the Wnt pathway in non-small-cell lung cancer.
Cheng L; Tong Q
Mol Cell Biochem; 2021 Oct; 476(10):3563-3575. PubMed ID: 34018148
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Song Z; Jia G; Ma P; Cang S
Life Sci; 2021 Jul; 276():119399. PubMed ID: 33781830
[TBL] [Abstract][Full Text] [Related]
19. The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications.
Yu M; Ji W; Yang X; Tian K; Ma X; Yu S; Chen L; Zhao X
Front Immunol; 2023; 14():1279735. PubMed ID: 38094306
[TBL] [Abstract][Full Text] [Related]
20. E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance.
Zheng G; Chen W; Li W; Ding Y; Tu P; Chen W
Biochem Biophys Res Commun; 2020 Oct; 530(4):624-631. PubMed ID: 32762943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
